Additionally, we previously demonstrated that combinatorial treatment with metformin and pembrolizumab enhanced anti-tumor immunity in STK11 mutant lung cancer via axis inhibition protein 1 (AXIN1)-dependent inhibition of STING ubiquitination [16]. This evidence concerns the gene AXIN1 and neoplasm.